REGENERON PHARMACEUTICALS, INC.

(REGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart REGENERON PHARMACEUTICALS, INC.
Upcoming events on REGENERON PHARMACEUTICALS, INC.
06/01/22 | 08:00am Bernstein Strategic Decisions Conference
06/10/22 | 10:30am Annual General Meeting
06/14/22 | 11:40am Goldman Sachs Global Healthcare Conference
08/04/22 Interim 2022 Earnings Release (Projected)
11/08/22 Q3 2022 Earnings Release (Projected)
02/09/23 FY 2022 Earnings Release (Projected)
05/04/23 Q1 2023 Earnings Release (Projected)
Past events on REGENERON PHARMACEUTICALS, INC.
05/10/22 | 04:20pm Bank of America Healthcare Conference
05/04/22 | 08:30am Q1 2022 Earnings Call
05/04/22 | 06:30am Q1 2022 Earnings Release
03/16/22 | 07:00am Barclays Global Healthcare Conference
03/15/22 | 09:00am Oppenheimer Healthcare Conference
03/08/22 | 01:30pm Cowen & Co. Health Care Conference
02/28/22 | 11:45am American academy of allergy, asthma and immunology meeting - poster no : 571
02/28/22 | 11:45am American academy of allergy, asthma and immunology meeting - oral no : 633
02/27/22 | 04:45pm American academy of allergy, asthma, and immunology conference - oral no : 434
02/27/22 | 11:45am American academy of allergy, asthma, and immunology conference - poster no : 377
Past dividends on REGENERON PHARMACEUTICALS, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
5 872
5 788
1,5%
6 711
6 520
2,9%
7 863
7 816
0,61%
8 497
8 494
0,04%
16 072
15 679
2,5%
 
11 844
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
2 732
2 658
2,8%
3 110
2 959
5,1%
3 420
3 610
-5,3%
4 245
4 158
2,1%
9 835
9 709
1,3%
 
5 944
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
2 080
2 094
-0,70%
2 534
2 424
4,5%
2 210
2 285
-3,3%
3 577
3 485
2,6%
8 947
9 040
-1,0%
 
4 899
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
2 079
2 075
0,16%
2 554
2 543
0,39%
2 429
2 308
5,3%
3 810
3 582
6,4%
9 326
9 442
-1,2%
 
4 968
 
Net income
M $
Released
Forecast
Spread
1 199
1 438
-17%
2 444
2 257
8,3%
2 116
1 998
5,9%
3 513
3 160
11%
8 075
8 014
0,77%
 
4 040
 
EPS
$
Released
Forecast
Spread
10,3
12,6
-18%
21,3
19,7
7,9%
18,5
17,6
4,7%
30,5
28,0
9,0%
72,0
71,1
1,2%
 
37,1
 
Announcement Date02/08/201802/06/201902/06/202002/05/202102/04/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Sales
M $
Released
Forecast
Spread
2 529
2 561
-1,3%
5 139
3 972
29%
3 453
2 800
23%
4 952
4 526
9,4%
2 965
2 690
10%
 
2 817
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
1 311
1 118
17%
3 564
2 813
27%
2 057
1 314
57%
2 903
2 564
13%
1 528
1 376
11%
 
1 303
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
1 113
1 040
7,0%
3 347
1 949
72%
1 847
1 278
45%
2 640
2 643
-0,13%
1 287
1 219
5,6%
 
1 222
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
1 253
1 079
16%
3 753
1 872
100%
1 817
1 392
30%
2 503
2 649
-5,5%
1 061
1 185
-10%
 
1 241
 
Net income
M $
Released
Forecast
Spread
1 115
953
17%
3 099
1 653
88%
1 632
1 152
42%
2 229
2 108
5,7%
974
1 038
-6,2%
 
923
 
EPS
$
Released
Forecast
Spread
10,1
8,31
21%
28,0
16,0
75%
14,3
10,7
34%
19,7
19,4
1,3%
8,61
8,77
-1,9%
 
9,06
 
Announcement Date05/06/202108/05/202111/04/202102/04/202205/04/2022-
Previous year Next Year
Upcoming sector events for REGENERON PHARMACEUTICALS, INC.
More events
Past sector events for REGENERON PHARMACEUTICALS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise